Low-glucose-containing peritoneal dialysis solutions: good or bad?

The authors discuss the results of a study which investigates the effects of low-glucose-containing peritoneal dialysis (PD) in patients with diabetes mellitus. An overview of the key findings of the IMPENDIA and EDEN trials including significant reduction in serum albumin, serum triglyceride, and very low-density lipoproteins are offered. The authors state that the two studies clarify the benefits and risks of using the PD but suggest caution when evaluating effectiveness.